RESTANTE, GIULIANA
 Distribuzione geografica
Continente #
NA - Nord America 1.759
AS - Asia 761
EU - Europa 614
SA - Sud America 96
AF - Africa 57
OC - Oceania 11
Totale 3.298
Nazione #
US - Stati Uniti d'America 1.693
SG - Singapore 278
IT - Italia 231
CN - Cina 190
HK - Hong Kong 111
BR - Brasile 80
VN - Vietnam 74
SE - Svezia 71
DE - Germania 69
GB - Regno Unito 57
BG - Bulgaria 52
CA - Canada 41
FR - Francia 41
CI - Costa d'Avorio 32
IN - India 22
FI - Finlandia 20
RU - Federazione Russa 18
JP - Giappone 17
AT - Austria 15
TR - Turchia 14
BD - Bangladesh 13
MX - Messico 10
AU - Australia 9
PL - Polonia 8
NG - Nigeria 7
NL - Olanda 7
AR - Argentina 6
KR - Corea 6
SN - Senegal 6
BE - Belgio 5
CR - Costa Rica 5
IQ - Iraq 5
PK - Pakistan 5
ES - Italia 4
IL - Israele 4
ZA - Sudafrica 4
BF - Burkina Faso 3
EC - Ecuador 3
GR - Grecia 3
JO - Giordania 3
LB - Libano 3
LT - Lituania 3
VE - Venezuela 3
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
JM - Giamaica 2
MA - Marocco 2
NZ - Nuova Zelanda 2
PA - Panama 2
PH - Filippine 2
TW - Taiwan 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BM - Bermuda 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
CO - Colombia 1
DK - Danimarca 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
ID - Indonesia 1
KE - Kenya 1
KZ - Kazakistan 1
LV - Lettonia 1
OM - Oman 1
PE - Perù 1
PT - Portogallo 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UA - Ucraina 1
UY - Uruguay 1
Totale 3.298
Città #
Ashburn 191
Fairfield 172
Singapore 134
Houston 129
Woodbridge 113
Hong Kong 108
Santa Clara 100
Chandler 98
San Jose 80
Dallas 78
Seattle 78
Cambridge 57
Sofia 52
Serra 47
Wilmington 46
Shanghai 43
Beijing 40
Pisa 40
Los Angeles 39
New York 38
London 36
Boardman 33
Abidjan 32
Ann Arbor 32
Princeton 28
Florence 26
Frankfurt am Main 25
Ottawa 22
Lawrence 20
Lauterbourg 19
Ho Chi Minh City 18
Munich 18
Medford 17
Tokyo 13
Vienna 13
Dearborn 12
Istanbul 12
Dong Ket 11
Milan 10
Turku 10
Des Moines 9
Helsinki 9
São Paulo 9
Buffalo 8
Hanoi 8
Redondo Beach 8
Turin 8
Boulder 7
Columbus 7
Lagos 7
Montreal 7
Nanjing 7
Orem 7
Warsaw 7
Brasília 6
Dakar 6
Fuzhou 6
Iowa City 6
Nuremberg 6
Paris 6
Redwood City 6
San Diego 6
San Francisco 6
Bremen 5
Cascina 5
Chennai 5
Chicago 5
Chiesina Uzzanese 5
Council Bluffs 5
Guangzhou 5
Kunming 5
Toronto 5
Washington 5
Brussels 4
Denver 4
Hefei 4
Norwalk 4
Phoenix 4
Quanzhou 4
Brooklyn 3
Dhaka 3
Johannesburg 3
La Spezia 3
Lahore 3
Manchester 3
Mexico City 3
Pistoia 3
San José 3
Amman 2
Baoding 2
Bientina 2
Boston 2
Campinas 2
Can Tho 2
Caserta 2
Changsha 2
Charleston 2
Chengdu 2
Chongqing 2
City of London 2
Totale 2.377
Nome #
PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC 324
The amount of activating EGFR mutations in circulating cell-free DNA is a marker to monitor osimertinib response 202
Concise Review: Chronic Myeloid Leukemia: Stem Cell Niche and Response to Pharmacologic Treatment 188
Understanding the Mechanisms of Resistance in EGFR-Positive NSCLC: From Tissue to Liquid Biopsy to Guide Treatment Strategy 179
Patients with NSCLC may display a low ratio of p.T790M vs. activating EGFR mutations in plasma at disease progression: implications for personalised treatment 178
Detection of ALK and KRAS Mutations in Circulating Tumor DNA of Patients With Advanced ALK-Positive NSCLC With Disease Progression During Crizotinib Treatment 169
Androgen receptor gain in circulating free DNA and splicing variant 7 in exosomes predict clinical outcome in CRPC patients treated with abiraterone and enzalutamide 169
Critical focus on mechanisms of resistance and toxicity of m-TOR inhibitors in pancreatic neuroendocrine tumors 168
Implications of KRAS mutations in acquired resistance to treatment in NSCLC 167
Pharmacogenetics and metabolism from science to implementation in clinical practice: the example of dihydropyrimidine dehydrogenase. 165
Unusual gastrointestinal and cutaneous toxicities by bleomycin, etoposide, and cisplatin: A case report with pharmacogenetic analysis to personalize treatment 156
Pharmacogenetics of androgen signaling in prostate cancer: focus on castration resistance and predictive biomarkers of response to treatment 154
From the beginning to resistance: study of plasma monitoring and resistance mechanisms in a cohort of patients treated with osimertinib for advanced T790M-positive NSCLC 154
Dabrafenib treatment in a patient with BRAF V600E ganglioglioma: circulating exosome-derived cancer RNA supports treatment choice and clinical monitoring 151
Genome Wide Association Studies (GWAS) 148
Endothelial nitric oxide synthase c.-813C>T predicts for proteinuria in metastatic breast cancer patients treated with bevacizumab-based chemotherapy 145
Incidence of T790M in Patients With NSCLC Progressed to Gefitinib, Erlotinib, and Afatinib: A Study on Circulating Cell-free DNA 131
Erratum: Clinical pharmacology of monoclonal antibodies targeting PD-1 axis in urothelial cancers 127
Concise Review: Resistance to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: The Role of Cancer Stem Cells 123
Clinical pharmacology of monoclonal antibodies targeting anti-PD-1 axis in urothelial cancers 120
null 70
Totale 3.388
Categoria #
all - tutte 10.992
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.992


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022196 3 4 3 3 40 37 8 6 14 7 9 62
2022/2023364 36 54 27 16 32 37 1 30 93 1 35 2
2023/2024233 15 14 46 10 19 47 6 6 3 14 30 23
2024/2025692 11 21 10 45 83 66 40 57 75 85 72 127
2025/2026824 59 87 55 119 127 46 143 32 53 71 25 7
2026/20275 5 0 0 0 0 0 0 0 0 0 0 0
Totale 3.388